Ellevest, Inc. Vertex Pharmaceuticals Inc Transaction History

Ellevest, Inc.

$1.8 Billion
Q3 2024

A detailed history of Ellevest, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Ellevest, Inc. holds 1,761 shares of VRTX stock, worth $793,101. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,761

Previous 1,747 0.8%

Holding current value

$793,101

Previous $818,000 0.12%

% of portfolio

0.05%

Previous 0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $6,440 - $7,080	14 Added 0.8%	1,761 $819,000
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $25,532 - $31,559	65 Added 3.86%	1,747 $818,000
Q1 2024 May 13, 2024	SELL	$407.69 - $446.08 $2,853 - $3,122	-7 Reduced 0.41%	1,682 $703,000
Q4 2023 Feb 06, 2024	SELL	$343.0 - $410.68 $41,503 - $49,692	-121 Reduced 6.69%	1,689 $687,000
Q3 2023 Nov 09, 2023	BUY	$338.18 - $362.46 $78,457 - $84,090	232 Added 14.7%	1,810 $629,000
Q2 2023 Aug 09, 2023	BUY	$314.42 - $351.91 $36,787 - $41,173	117 Added 8.01%	1,578 $555,000
Q1 2023 May 04, 2023	BUY	$283.23 - $323.1 $75,055 - $85,621	265 Added 22.16%	1,461 $460,000
Q4 2022 Feb 03, 2023	BUY	$285.76 - $321.48 $29,433 - $33,112	103 Added 9.42%	1,196 $345,000
Q3 2022 Nov 02, 2022	BUY	$273.83 - $305.53 $64,350 - $71,799	235 Added 27.39%	1,093 $316,000
Q2 2022 Jul 18, 2022	BUY	$234.96 - $292.55 $151,549 - $188,694	645 Added 302.82%	858 $242,000
Q1 2022 Apr 19, 2022	SELL	$221.42 - $260.97 $9,078 - $10,699	-41 Reduced 16.14%	213 $56,000
Q4 2021 Jan 24, 2022	SELL	$177.01 - $223.45 $200,375 - $252,945	-1,132 Reduced 81.67%	254 $56,000
Q3 2021 Oct 19, 2021	SELL	$181.39 - $202.99 $12,878 - $14,412	-71 Reduced 4.87%	1,386 $251,000
Q2 2021 Jul 13, 2021	BUY	$187.49 - $221.1 $50,809 - $59,918	271 Added 22.85%	1,457 $294,000
Q1 2021 May 03, 2021	BUY	$207.02 - $241.31 $44,509 - $51,881	215 Added 22.14%	1,186 $255,000
Q4 2020 Feb 04, 2021	BUY	$207.01 - $276.09 $35,398 - $47,211	171 Added 21.38%	971 $229,000
Q3 2020 Oct 26, 2020	BUY	$255.65 - $303.1 $41,159 - $48,799	161 Added 25.2%	800 $218,000
Q2 2020 Jul 06, 2020	BUY	$225.48 - $295.8 $69,222 - $90,810	307 Added 92.47%	639 $186,000
Q1 2020 Apr 13, 2020	BUY	$199.77 - $247.81 $22,174 - $27,506	111 Added 50.23%	332 $79,000
Q4 2019 Feb 05, 2020	BUY	$166.71 - $223.91 $33,342 - $44,782	200 Added 952.38%	221 $48,000
Q3 2019 Oct 08, 2019	SELL	$166.23 - $187.09 $1,662 - $1,870	-10 Reduced 32.26%	21 $4,000
Q2 2019 Aug 20, 2019	BUY	$164.61 - $190.37 $1,810 - $2,094	11 Added 55.0%	31 $6,000
Q4 2018 Jan 25, 2019	BUY	$151.91 - $192.21 $3,038 - $3,844	20 New	20 $3,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Account